TG Therapeutics Q1 2026 Earnings EPS Misses Expectations Despite Stock Gain SSSSL Q1 2026 Earnings EPS of 518 Surges Past Negative Estimate Net Asset Value May Drive Surprise SPIR Q1 2026 Earnings Earnings Miss Meets Positive Stock Reaction Amid Strategic Shifts SYF Q1 2026 Earnings Earnings Beat as Credit Quality Remains Resilient BVN Q4 2025 Earnings Strong EPS Surprise Driven by Operational Gains VICR Q1 2026 Earnings EPS Surprises 1983 Above Estimates as Stock Declines Slightly